Mycotoxin

LabRoots' Analytical Chemistry & Separation Sciences Virtual Event, Serves as a Stage for Experts and Disciplines in Pharmaceutical Analysis and Analytical Chemistry

Thursday, October 14, 2021 - 3:00pm

Participants will endure a unique educational opportunity to hear lectures from prominent speakers working in the areas of small molecular separation analysis, food and environmental analysis, and biopharmaceutical analytical technologies.

Key Points: 
  • Participants will endure a unique educational opportunity to hear lectures from prominent speakers working in the areas of small molecular separation analysis, food and environmental analysis, and biopharmaceutical analytical technologies.
  • "As the technology surrounding analytical chemistry continues to evolve, it is imperative to stay deeply connected in this rapidly growing science," commented Adam Floyd, Co-Founder of Cascade Laboratory Consulting, and Steering Committee Member.
  • The use of Labroots' dynamic digital platform allows for unrestricted access to the unique and talented speakers contributing to this meeting."
  • Labroots, an approved provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.

DGAP-News: Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF(TM)

Thursday, October 14, 2021 - 2:29pm

Since the beginning of the clinical development program in late-2016, QIXLEEF(TM) strictly adhered to and complied with the regulatory requirements of a prescription drug.

Key Points: 
  • Since the beginning of the clinical development program in late-2016, QIXLEEF(TM) strictly adhered to and complied with the regulatory requirements of a prescription drug.
  • Having a global drug development strategy ensures economy of scale and lower cost of drug development to shareholders.
  • The REBORN(c) clinical strategy provides the fastest and lowest cost development program to bring QIXLEEF(TM) to the market.
  • Guy Chamberland, CEO and CRO commented, "Our team has made significant progress in bringing QIXLEEF(TM) to a late clinical development stage.

Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™

Thursday, October 14, 2021 - 11:30am

Since the beginning of the clinical development program in late-2016, QIXLEEF strictly adhered to and complied with the regulatory requirements of a prescription drug.

Key Points: 
  • Since the beginning of the clinical development program in late-2016, QIXLEEF strictly adhered to and complied with the regulatory requirements of a prescription drug.
  • The Company completed two Phase 1 clinical trials in healthy volunteers to assess the safety profile, including cardiovascular, pharmacodynamics and pharmacokinetics, of smoked and vaporized QIXLEEF.
  • The REBORN clinical strategy provides the fastest and lowest cost development program to bring QIXLEEF to the market.
  • Guy Chamberland, CEO and CRO commented, "Our team has made significant progress in bringing QIXLEEF to a late clinical development stage.

Global Food Traceability Market 2021-2026 | COVID-19 Pandemic has Heightened Consumer Concerns Regarding the Significance of Safe & Healthy Eating Habits - ResearchAndMarkets.com

Wednesday, October 6, 2021 - 9:28am

The sudden outbreak of the COVID-19 pandemic has positively impacted the growth of the Global Food Traceability Market.

Key Points: 
  • The sudden outbreak of the COVID-19 pandemic has positively impacted the growth of the Global Food Traceability Market.
  • It is due to rising consumer concerns regarding the significance of safe and healthy eating habits.
  • Of these four, Food Manufacturers acquired the largest share of the Global Food Traceability Market in the previous years.
  • What are the overall market statistics or estimates (Market Overview, Market Size- by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global Food Traceability Market?

Si-Ware™ Systems and Dairyland Laboratories Partner to Launch In-Field Dairy Feed Analysis Solution

Tuesday, September 28, 2021 - 3:00pm

Dairylands NIR support and data integrations will be made available on Si-Wares NeoSpectra LabStore via the Dairyland Feed Analysis app.

Key Points: 
  • Dairylands NIR support and data integrations will be made available on Si-Wares NeoSpectra LabStore via the Dairyland Feed Analysis app.
  • We are thrilled to partner with Dairyland Laboratories to launch new dairy feed testing models on the NeoSpectra LabStore, said Youssri Helmy , CEO of Si-Ware Systems.
  • Our work with Dairyland will help deliver on this vision and will provide instant feed analysis insights for farmers, laboratories, ingredient suppliers, feed mills, dairy consultants, and more.
  • Dairyland Laboratories is an independent agricultural laboratory providing analysis of feed, forage, soil, water, manure, molds and mycotoxins.

InBOLD Inc. Announces Issuance of a New Patent on Cannabinoid Composition and Delivery System

Friday, September 17, 2021 - 1:44pm

SANTA CRUZ, Calif., Sept. 17, 2021 /PRNewswire/ --InBOLD Inc. announcedthe issuance of a U.S. Patent 16/424,351, a Cannabinoid Composition and Method of Sublingual, Buccal, and Oral Mucosa Delivery.

Key Points: 
  • SANTA CRUZ, Calif., Sept. 17, 2021 /PRNewswire/ --InBOLD Inc. announcedthe issuance of a U.S. Patent 16/424,351, a Cannabinoid Composition and Method of Sublingual, Buccal, and Oral Mucosa Delivery.
  • "This is exemplary of the importance of R&D and our intellectual property as part of our strategy.
  • This patent focuses on a formulation that includes a cannabinoid extract that is pharmaceutically effective by systemic deliveryto therecipient's oral mucosal lining.
  • Our portfolio of cannabinoid products unites best practices from the pharmaceutical, medical, and natural products industry creating best-in-class cannabinoid therapeutics and supplements with full traceability.

Purity Coffee's Explosive Growth Places Them in Top 200 of the Coveted Inc. 5000 List

Wednesday, September 1, 2021 - 2:00pm

In the three years to follow, Purity Coffee would grow its revenue by 2,224% and today, its holding on to nearly 90% of its subscribers.

Key Points: 
  • In the three years to follow, Purity Coffee would grow its revenue by 2,224% and today, its holding on to nearly 90% of its subscribers.
  • The result is Purity Coffee being catapulted into the top 200 of the prestigious Inc. 5000 list in 2021.
  • We apply scientific research to each step of the coffee production process, says Andrew Salisbury, Founder and CEO of Purity Coffee.
  • Purity Coffee uses only organic coffee beans from regenerative, biodynamic farms which are Rainforest Alliance and Smithsonian Bird Friendly certified.

Endorsed by the American Cannabinoid Association, ACS Laboratory Launches Its Tested Safe Certified Seal Program to Elevate Industry Standards and Consumer Trust

Tuesday, August 24, 2021 - 1:49pm

ACS Laboratory's Tested Safe Certified Safety Seal is a physical symbol that products passed the strictest testing guidelines in the U.S. by an award-winning medical-grade laboratory.

Key Points: 
  • ACS Laboratory's Tested Safe Certified Safety Seal is a physical symbol that products passed the strictest testing guidelines in the U.S. by an award-winning medical-grade laboratory.
  • "We developed the trademarked Tested Safe Certified Seal to provide consumers and patients with reassurance that their cannabis and hemp products are clean and safe to ingest," said Roger Brown, president and founder of ACS Laboratory.
  • "Factors ranging from manufacturing errors to false laboratory results have led to mislabeled products, negative headlines, and a breakdown of consumer confidence.
  • "The American Cannabinoid Association proudly endorses ACS Laboratory's Tested Safe Certified Seal program," stated Matthew Guenther, founder of The American Cannabinoid Association.

The Valens Company Enhances Testing Capabilities to Prepare for International Industry Market Expansion

Monday, August 16, 2021 - 10:00pm

KELOWNA, BC, Aug. 16, 2021 /PRNewswire/ -The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products,today announced that it continues to prepare for international industry growth with upgrades to its leading-edge research and ISO/IEC 17025:2017 accredited testing facility, Valens Labs.

Key Points: 
  • KELOWNA, BC, Aug. 16, 2021 /PRNewswire/ -The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products,today announced that it continues to prepare for international industry growth with upgrades to its leading-edge research and ISO/IEC 17025:2017 accredited testing facility, Valens Labs.
  • Valens Labs' testing capabilities have been enhanced to now further satisfy various additional international testing requirements for finished cannabis goods to support existing and future customers looking to expand their export capabilities.
  • The enhanced validation methods that Valens Labs now offers are in preparation for changes in certain international analytics and testing requirements.
  • Valens' third-party testing services now allows for the testing of more than 300 pesticides, making it the only cannabis testing lab in Canada with the capabilities to test this magnitude of containments at commercial capacity.

Mycotoxin Binders Market is expected to witness a steady growth rate of 4.5% over the forecast period of 2021 to 2031 - Persistence Market Research

Tuesday, July 13, 2021 - 11:30am

NEW YORK, July 13, 2021 /PRNewswire/ --The global mycotoxin binders market share is expected to witness a steady growth rate of 4.5% over the forecast period of 2021 to 2031.

Key Points: 
  • NEW YORK, July 13, 2021 /PRNewswire/ --The global mycotoxin binders market share is expected to witness a steady growth rate of 4.5% over the forecast period of 2021 to 2031.
  • One of the favorable reasons for growth in demand for mycotoxin binders is increased attention to proper animal nutrition in order to preserve the animal's health and efficiency.
  • Request for sample PDF of report: https://www.persistencemarketresearch.com/samples/32561
    The global mycotoxin binders market is set to witness substantial 1.5X volume growth over the forecast period of 2021 to 2031, owing to increased customer demand for high quality meat and poultry products.
  • Get full access of report: https://www.persistencemarketresearch.com/checkout/32561
    Persistence Market Research, in its new report, offers an impartial analysis of the global mycotoxin binders market, presenting historical data (2016-2020) and estimation statistics for the forecast period of 2021-2031.